Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
PEPG
$4.98
-8.29%
Analyze
1M
-15.3%
3M
+245.8%
1Y
-39.5%
Market Cap:
$163.34M
PepGen Ltd
Healthcare |
Biotechnology
PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious neurological and neuromuscular diseases. The company is headquartered in Cambridge, Massachusetts.
Click "Analyze" to generate stock analysis
PEPG Price Trend and Signals
PEPG Option Volumes & Open Interests (aggregated)
PEPG Put Call Ratios and IV (aggregated)
PEPG Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-27
Somewhat Bullish
price_signal
Monthly high detected.
2025-10-27
Bullish
price_signal
Large price change detected: 18.82%.
2025-10-13
Somewhat Bearish
macd_signal
Dead cross above zero detected.